Clinical trials: Blood Glucose Self Monitoring
Diabetes Mellitus, Type 1
Metabolic Effects of Accurate Blood Sugar Results and Education in Type 1 Diabetes
A randomized controlled trial in patients with type 1 diabetes, assessing the metabolic effects of accurate blood sugar results and education.
- Trial name
- NCT00284232
- Testing
- Use and interpretation of blood glucose results, Insulin dosing based on SMBG chart and education
- Where
- Norway
- Volunteers
- 140 people
- Sponsor
- Helse Stavanger HF
Diabetes Mellitus, Type 1
Comparison of Real-tiMe ContInuous gLucosE moNitoriNg With Self-monitorIng of Blood Glucose in Young AduLts With Type 1 diabeteS
The main objective of this study is to determine whether real-time continuous glucose monitoring (CGM) for 8 weeks is more efficacious compared to self-monitoring of blood glucose (SMBG) in young adults with type 1 diabetes.
- Trial name
- MILLENNIALS (NCT03445377)
- Testing
- Real-time continuous glucose monitoring, Self-monitoring of blood glucose
- Where
- United Kingdom
- Volunteers
- 32 people
- Sponsor
- Manchester University NHS Foundation Trust
Type 2 Diabetes
Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring
The purpose of this study is to evaluate the effectiveness of Self Monitoring of Blood Glucose (SMBG) for clinical decisions related to the management of type 2 diabetes and to determine the benefit of using Continuous Glucose…
- Trial name
- NCT01072565
- Testing
- SMBG to guide clinical decisions, SMBG and CGM
- Where
- United States
- Volunteers
- 91 people
- Sponsor
- HealthPartners Institute
Type 1 Diabetes
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
The Diabetes Interactive Diary (DID) is both a CHO (carbohydrates )/insulin bolus calculator, an information technology and a telemedicine system based on the communication between health care professional and patient by SMS…
- Trial name
- DID3 (NCT01192711)
- Testing
- Diabetes Interactive Diary (DID)
- Where
- 13 sites in Italy
- Volunteers
- 130 people
- Sponsor
- Consorzio Mario Negri Sud
Diabetes, Gestational, Gastric Bypass Status for Obesity Complicating Pregnancy, Childbirth, or the Puerperium
Gestational Diabetes After Gastric Bypass Surgery
The goal of this trial is to compare different means of glucose monitoring in women with gestational diabetes and a history of gastric bypass surgery.
- Conditions
- Diabetes, Gestational, Gastric Bypass Status for Obesity Complicating Pregnancy, Childbirth, or the Puerperium, Pregnancy in Diabetic, Blood Glucose Self Monitoring
- Trial name
- NCT06291766
- Testing
- FreeStyle Libre 2, continous glucose monitoring
- Where
- Sweden
- Volunteers
- 120 people
- Sponsor
- Region Skane
Diabetes Mellitus, Type 2
Efficacy of Insulin Lispro Mix 50/50 Therapy
Insulin therapy with lispro mix 50/50 t.i.d. is a treatment with a single insulin device. The management is comparatively simple and easy, but the curative effect is promising.
- Trial name
- NCT01303042
- Testing
- Insulin lispro mix 50/50
- Where
- 4 sites in Japan
- Volunteers
- 80 people
- Sponsor
- Aichi Gakuin University
Diabetes Mellitus, Type 2
Self-monitoring of Blood Glucose in Insulin-treated Patients With Type 2 Diabetes
Primary Objective: The objective of the study is to investigate the effect of a specific frequency of Self-monitoring of blood glucose (SMBG) on glycemic control and quality of life in patients with type 2 diabetes and who are in…
- Trial name
- NCT01460459
- Testing
- a specific frequency of SMBG
- Where
- Netherlands
- Volunteers
- 150 people
- Sponsor
- Medical Research Foundation, The Netherlands
Diabetes Mellitus
Efficacy of a Chronic Care Model Supported by Self Monitoring of Blood Glucose With BGStar Over Usual Care in Improving Glycemic Control in Patients With Type 2 Diabetes Not Treated With Insulin
To demonstrate the superiority of a chronic care model (SINERGIA model) supported by the Self Monitoring of Blood Glucose with BGStar over usual care in improving glycemic control at 12 months in patients with type 2 diabetes not…
- Trial name
- SELF CARE (NCT02082028)
- Testing
- BGStar, glucose meter
- Where
- 20 sites in Italy
- Volunteers
- 241 people
- Sponsor
- Sanofi
Type 2 Diabetes
Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving Insulin
The aim of this pilot study is to evaluate the validity and feasibility of an educational approach involving nurses, combined with SMBG, aimed at lifestyle modification and timely changes in therapy, when needed.
- Trial name
- ROSES (NCT01176149)
- Testing
- SMBG plus intensive education
- Where
- Italy
- Volunteers
- 62 people
- Sponsor
- Consorzio Mario Negri Sud
Type 2 Diabetes Treated With Insulin
Steno2tech - Continuous Glucose Monitoring and Type 2 Diabetes.
The overall objective of this research study is to examine the effectiveness of the use of CGM vs. SMBG in persons with insulin-treated type 2 diabetes on glycemic variables and patient reported outcomes on treatment…
- Trial name
- NCT04331444
- Testing
- CGM, training course, Peer-support
- Where
- Denmark
- Volunteers
- 96 people
- Sponsor
- Steno Diabetes Center Copenhagen
Diabetes Mellitus
Blood Glucose Monitoring in Electronic Health Records
This multi-site randomized tral aims to test methods of increasing adoption and integration of blood glucose monitoring into electronic medical records, and to measure the impact of wide-scale adoption on health status of…
- Trial name
- NCT03542487
- Testing
- Practice Orientation, Standard Reminder, Gift Card Reminder
- Where
- United States
- Volunteers
- 7,052 people, healthy volunteers welcome
- Sponsor
- Inova Health Care Services
Gestational Diabetes, Gestational Diabetes Mellitus in Pregnancy
Treatment Satisfaction and Treatment Adherence of Diabetic Women Through the Use of FGM
The incidence of gestational diabetes mellitus (GDM), a glucose tolerance disorder during pregnancy, is increasing. In Germany, it reached 8.58 % in 2019. Standardized treatment has reduced complications for mother and child.
- Trial name
- Flash (NCT05924724)
- Testing
- Flash Glucose Monitoring
- Where
- Germany
- Volunteers
- 100 people
- Sponsor
- Jena University Hospital
Diabetes Mellitus, Type 1
Pediatrics Owning Performance Study
A more convenient blood glucose monitoring system integrated with a responsive mobile health app may facilitate improved diabetes control in adolescent and young adult patients with Type 1 diabetes.
- Trial name
- POPS! (NCT03251846)
- Testing
- Pops! One personalized mobile platform
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- Children's Hospitals and Clinics of Minnesota
Diabetes Mellitus
To Evaluate the Efficacy and Safety of Multi-parameter Non-Invasive Glucose Sensors for for Blood Glucose Measurement
This was a prospective, multicenter, open-label, self-controlled study to evaluate the efficacy and safety of multi-parameter non-invasive glucose meters for blood glucose measurement，planned enrollment of 200 patients with type…
- Trial name
- NCT06017349
- Testing
- Non-invasive glucose meter, EKF analyzer, Accu-Chek Guide
- Where
- China
- Volunteers
- 200 people
- Sponsor
- Lepu Medical Technology (Beijing) Co., Ltd.
Diabetes Mellitus, Type 2
Effect of Self-monitoring of Blood Glucose in Patients With Type 2 Diabetes Mellitus Not Using Insulin
Self-monitoring of blood glucose (SMBG) is one of the important instruments in diabetes management. Most patients with type 1 diabetes and patients with type 2 using insulin, frequently measure their blood glucose in case of…
- Trial name
- NCT00287807
- Testing
- Self-monitoring of blood glucose (SMBG)
- Where
- Netherlands
- Volunteers
- 60 people
- Sponsor
- Medical Research Foundation, The Netherlands
Diabetes Mellitus, Type 2
ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.
The primary objective of the present study is to verify the superiority of Telecare program vs. standard SMBG program in terms of mean HbA1c value (- 0,5%) at end-point.
- Trial name
- NCT00272064
- Testing
- Insulin glulisine, Insulin glargine, Metformin
- Where
- Italy
- Volunteers
- 352 people
- Sponsor
- Sanofi
Cardiovascular Diseases, Hypertension
Uppsala Self-Screening of Cardiovascular Health
U-SCREEN is a randomized controlled trial evaluating whether systematic home-based multimodal screening for cardiovascular risk conditions, offered to residents in Region Uppsala turning 50, 55, 60, 65, 70 or 75 years of age, can…
- Conditions
- Cardiovascular Diseases, Hypertension, Dyslipidemias, Diabetes Mellitus
- Trial name
- U-SCREEN (NCT07614659)
- Testing
- Home-based multimodal cardiovascular screening
- Where
- Sweden
- Volunteers
- 45,000 people, healthy volunteers welcome
- Sponsor
- Johan Sundström
Diabetes Mellitus, Non-Insulin-Dependent
Education and Group Support for Diabetic Hispanics
The purpose of this ongoing work in Starr County, located on the Texas-Mexico border, is to conduct clinical studies to determine the effectiveness of diabetes self-management programs designed specifically for Mexican Americans.
- Trial name
- NCT00004983
- Testing
- diabetes self-management education
- Where
- United States
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Mellitus Type 2
PRISMA Study (Prospective, Randomized Trial on Intensive Self-Monitoring Blood Glucose Management Added Value in Non-Insulin Treated Type 2 Diabetes Mellitus Patients)
This randomized, parallel study compares 2 groups of type 2 non-insulin treated (NIT) diabetes patients using the Accu-Chek Aviva glucometers.
- Trial name
- NCT00643474
- Testing
- Accu-Chek Aviva Meter
- Where
- 43 sites in Italy
- Volunteers
- 1,000 people
- Sponsor
- Hoffmann-La Roche
Type 2 Diabetes Mellitus
Quality Initiative to Improve Glucose Control in Type 2 Diabetic Patients
The goal of the Twine / University of Michigan Diabetes Quality Improvement Initiative is to improve diabetes care quality using real time feedback with continuous glucose monitoring (CGM) and dietary coaching for lower…
- Trial name
- NCT03705260
- Testing
- Usual Care, Intensive Behavioral Intervention, Monthly Screening for Risk
- Where
- United States
- Volunteers
- 64 people
- Sponsor
- University of Michigan